Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2009-07-21 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: EPINAL (88000), Vosges
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE GWINNER MARCHAL is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in EPINAL (88000),
this company of category PME
shows in 2018 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE GWINNER MARCHAL (SIREN 513868620)
Indicator
2024
2023
2022
2021
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
2 913 416 €
N/C
Net income
98 339 €
100 509 €
209 840 €
219 410 €
114 636 €
178 302 €
-89 271 €
EBITDA
N/C
N/C
N/C
N/C
N/C
218 357 €
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
6.1%
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE GWINNER MARCHAL generates positive net income of 98 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
98 339 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 92%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
92.283%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
46.702%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
Debt ratio
131.504
100.511
67.951
41.989
32.884
95.378
92.283
Financial autonomy
37.307
43.685
50.71
60.579
62.451
43.052
46.702
Repayment capacity
None
7.097
None
None
None
None
None
Cash flow / Revenue
None%
6.167%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
92.282024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+30 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE GWINNER ... (92.28) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
46.7%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average-24 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE GWINNER ... (46.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 158.73. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2021
2022
2023
2024
Liquidity ratio
189.911
206.016
137.981
178.985
128.715
106.24
158.734
Interest coverage
None
9.582
None
None
None
None
None
Sector positioning
Liquidity ratio
158.732024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+16 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE GWINNER ... (158.73) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE GWINNER MARCHAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
Operating WCR
0 €
456 620 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
46
0
0
0
0
0
Customer payment term (days)
0
9
0
0
0
0
0
Supplier payment term (days)
0
50
0
0
0
0
0
Positioning of SELARL PHARMACIE GWINNER MARCHAL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE GWINNER MARCHAL is estimated at
1 372 885 €
(range 956 055€ - 2 053 914€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
956k€1372k€2053k€
1 372 885 €Range: 956 055€ - 2 053 914€
NAF 5 année 2024
Valuation method used
Net Income Multiple
98 339 €
×
14.0x
=1 372 885 €
Range: 956 056€ - 2 053 915€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE GWINNER MARCHAL with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE GWINNER MARCHAL
What is the revenue of SELARL PHARMACIE GWINNER MARCHAL ?
The revenue of SELARL PHARMACIE GWINNER MARCHAL in 2018 is 2.9 M€.
Is SELARL PHARMACIE GWINNER MARCHAL profitable?
Yes, SELARL PHARMACIE GWINNER MARCHAL generated a net profit of 98 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE GWINNER MARCHAL ?
The headquarters of SELARL PHARMACIE GWINNER MARCHAL is located in EPINAL (88000), in the department Vosges.
Where to find the tax return of SELARL PHARMACIE GWINNER MARCHAL ?
The tax return of SELARL PHARMACIE GWINNER MARCHAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE GWINNER MARCHAL operate?
SELARL PHARMACIE GWINNER MARCHAL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart